Abstract

A wide spectrum of drugs have been assessed as latency reversal agents (LRA) to reactivate HIV-1 from cellular reservoirs and aid in viral eradication strategies. Histone deacetylase inhibitors (HDACi) have been studied in vitro and in vivo as potential candidates for HIV-1 latency reversion. Suberoylanilide hydroxamic acid (SAHA) and romidepsin (RMD) are two HDACi able to reverse HIV latency, however studies of potential off-target effects on retroelement expression have been limited. Retroelements constitute a large portion of the human genome, and some are considered “fossil viruses” as they constitute remnants of ancient exogenous retroviruses infections. Retroelements are reactivated during certain disease conditions like cancer or during HIV-1 infection. In this study, we analyzed differential expression of retroelements using publicly available RNA-seq datasets (GSE102187 and GSE114883) obtained from uninfected CD4+, and HIV-1 latently infected CD4+ T-cells treated with HDACi (SAHA and RMD). We found a total of 712 and 1,380 differentially expressed retroelements in HIV-1 latently infected cells following a 24-h SAHA and RMD treatment, respectively. Furthermore, we found that 531 retroelement sequences (HERVs and L1) were differentially expressed under both HDACi treatments, while 1,030 HERV/L1 were exclusively regulated by each drug. Despite differences in specific HERV loci expression, the overall pattern at the HERV family level was similar for both treatments. We detected differential expression of full-length HERV families including HERV-K, HERV-W and HERV-H. Furthermore, we analyzed the link between differentially expressed retroelements and nearby immune genes. TRAF2 (TNF receptor) and GBP5 (inflammasome activator) were upregulated in HDACi treated samples and their expression was correlated with nearby HERV (MERV101_9q34.3) and L1 (L1FLnI_1p22.2k, L1FLnI_1p22.2j, L1FLnI_1p22.2i). Our findings suggest that HDACi have an off-target effect on the expression of retroelements and on the expression of immune associated genes in treated CD4+ T-cells. Furthermore, our data highlights the importance of exploring the interaction between HIV-1 and retroelement expression in LRA treated samples to understand their role and impact on “shock and kill” strategies and their potential use as reservoir biomarkers.

Highlights

  • Half of the human genome is composed of ancient transposable elements (TE), initially termed “selfish DNA parasites” or “junk DNA.” TEs are divided in two general groups, DNA transposons and retroelements, and have shown a role in disease development and viral infection [1,2,3]

  • Our findings show that Histone deacetylase inhibitors (HDACi) modulate retroelement and immune gene expression, suggesting that “shock and kill” strategy mediated by Suberoylanilide hydroxamic acid (SAHA) and RMD treatment induces genes expression, which could be used as biomarkers during latency reversal agents (LRA) treatment

  • To determine if LRA treatment can modulate retrotransposons expression in non-HIV-1 infected T CD4+ cells, we used Telescope to investigate the transcriptional modulation of retroelements in naïve CD4+ T-cells from four healthy HIV1-negative donors treated with SAHA over a 24-h period (White et al dataset)

Read more

Summary

Introduction

Half of the human genome is composed of ancient transposable elements (TE), initially termed “selfish DNA parasites” or “junk DNA.” TEs are divided in two general groups, DNA transposons and retroelements, and have shown a role in disease development and viral infection [1,2,3]. In contrast to SINE, L1 are autonomous elements able to replicate and insert into the human genome [7,8,9] Both HERV and L1 expression are associated with human diseases and with viral infections, such as HIV-1 [10,11,12,13]. Both HERV and HIV-1 belong to the Retroviridae family of RNA viruses that replicate through a DNA intermediate. Their complete genome is composed by gag, pol and env genes flanked by two LTR regions. In contrast to HERV, HIV-1 is an exogenous retrovirus, with a similar genetic structure but capable of infecting human CD4+ T-cells which can lead to the development of AIDS in absence of antiretroviral treatment (ART)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call